Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | Chief Operating Officer | April 01, 2022 | April 05, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date April 01, 2022 · Filed April 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 47,401 |
Reported balance
After 2022-04-01 transaction · row 1
1 source rowRow 1 · 2022-04-01 · Tax withholding · Disposed 384 · Balance 47,401 F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2021 Filed Jul 6, 2021 23:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 236 | $131.48 | $31,029.28 |
DisclosureSEC source: 0001214659-21-007319 · marketforms-53261.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,740 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 827 | $0.00 Strike: $25.02 | $0.00 |
DisclosureSEC source: 0001214659-21-006945 · marketforms-53196.xml · derivative · entry 7 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,821 Underlying: Common Stock · 827 shares Expires 2029-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,974 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-21-006945 · marketforms-53196.xml · derivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,220 Underlying: Common Stock · 1,974 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,104 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-21-006945 · marketforms-53196.xml · derivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,417 Underlying: Common Stock · 2,104 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,905 | $118.34 | $580,457.70 |
DisclosureSEC source: 0001214659-21-006945 · marketforms-53196.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,976 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 15, 2020. Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 827 | $25.02 | $20,691.54 |
DisclosureSEC source: 0001214659-21-006945 · marketforms-53196.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 1,974 | $26.66 | $52,626.84 |
DisclosureSEC source: 0001214659-21-006945 · marketforms-53196.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 2,104 | $8.82 | $18,557.28 |
DisclosureSEC source: 0001214659-21-006945 · marketforms-53196.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 24, 2021 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 1,228 | $97.75 | $120,037.00 |
DisclosureSEC source: 0001214659-21-005863 · marketforms-52894.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,976 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 827 | $0.00 Strike: $25.02 | $0.00 |
DisclosureSEC source: 0001214659-21-005821 · marketforms-52853.xml · derivative · entry 7 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,648 Underlying: Common Stock · 827 shares Expires 2029-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,974 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-21-005821 · marketforms-52853.xml · derivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,194 Underlying: Common Stock · 1,974 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,104 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-21-005821 · marketforms-52853.xml · derivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,521 Underlying: Common Stock · 2,104 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,905 | $88.39 | $433,552.95 |
DisclosureSEC source: 0001214659-21-005821 · marketforms-52853.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,204 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 15, 2020. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 827 | $25.02 | $20,691.54 |
DisclosureSEC source: 0001214659-21-005821 · marketforms-52853.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 1,974 | $26.66 | $52,626.84 |
DisclosureSEC source: 0001214659-21-005821 · marketforms-52853.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 2,104 | $8.82 | $18,557.28 |
DisclosureSEC source: 0001214659-21-005821 · marketforms-52853.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 21:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 280 | $133.12 | $37,273.60 |
DisclosureSEC source: 0001214659-21-004542 · marketforms-52308.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,204 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 827 | $0.00 Strike: $25.02 | $0.00 |
DisclosureSEC source: 0001214659-21-004440 · marketforms-52314.xml · derivative · entry 7 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,475 Underlying: Common Stock · 827 shares Expires 2029-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,974 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-21-004440 · marketforms-52314.xml · derivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,168 Underlying: Common Stock · 1,974 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,105 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-21-004440 · marketforms-52314.xml · derivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,625 Underlying: Common Stock · 2,105 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,906 | $124.42 | $610,404.52 |
DisclosureSEC source: 0001214659-21-004440 · marketforms-52314.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,484 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 15, 2020. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 827 | $25.02 | $20,691.54 |
DisclosureSEC source: 0001214659-21-004440 · marketforms-52314.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 1,974 | $26.66 | $52,626.84 |
DisclosureSEC source: 0001214659-21-004440 · marketforms-52314.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 2,105 | $8.82 | $18,566.10 |
DisclosureSEC source: 0001214659-21-004440 · marketforms-52314.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,589 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:34 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 235 | $122.20 | $28,717.00 |
DisclosureSEC source: 0001214659-21-003959 · ownership.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,484 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| April 01, 2021 Filed Apr 7, 2021 14:50 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 235 | $122.20 | $28,717.00 |
DisclosureSEC source: 0001214659-21-004001 · marketforms-52194.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,484 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,654 | $0.00 Strike: $25.02 | $0.00 |
DisclosureSEC source: 0001214659-21-003501 · marketforms-52092.xml · derivative · entry 7 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,302 Underlying: Common Stock · 1,654 shares Expires 2029-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,948 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-21-003501 · marketforms-52092.xml · derivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,142 Underlying: Common Stock · 3,948 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,037 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-21-003501 · marketforms-52092.xml · derivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,730 Underlying: Common Stock · 9,037 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 14,639 | $132.50 | $1,939,667.50 |
DisclosureSEC source: 0001214659-21-003501 · marketforms-52092.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,719 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 15, 2020. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 1,654 | $25.02 | $41,383.08 |
DisclosureSEC source: 0001214659-21-003501 · marketforms-52092.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 3,948 | $26.66 | $105,253.68 |
DisclosureSEC source: 0001214659-21-003501 · marketforms-52092.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 9,037 | $8.82 | $79,706.34 |
DisclosureSEC source: 0001214659-21-003501 · marketforms-52092.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:56 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 1,126 | $150.81 | $169,812.06 |
DisclosureSEC source: 0001214659-21-002299 · marketforms-51555.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,719 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 22:49 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 263 | $190.64 | $50,138.32 |
DisclosureSEC source: 0001214659-21-000830 · marketforms-51257.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,845 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:54 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 242 | $141.29 | $34,192.18 |
DisclosureSEC source: 0001214659-21-000151 · marketforms-50798.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,108 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,754 | $0.00 Strike: $25.02 | $0.00 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · derivative · entry 16 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,956 Underlying: Common Stock · 10,754 shares Expires 2029-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: 25% of the shares subject to the option vested on October 24, 2020 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 25,662 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · derivative · entry 15 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,090 Underlying: Common Stock · 25,662 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The option is immediately exercisable. 20% of the shares subject to the option vested on October 31, 2019 and 1/60th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,584 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · derivative · entry 14 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,767 Underlying: Common Stock · 3,584 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 100 | $148.73 | $14,873.00 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · nonDerivative · entry 13 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,350 Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,018 | $147.95 | $742,430.66 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · nonDerivative · entry 12 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,450 F9 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $147.72 to $148.68 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 7,751 | $147.13 | $1,140,382.15 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · nonDerivative · entry 11 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,468 F8 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $146.71 to $147.69 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,476 | $146.15 | $800,305.90 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · nonDerivative · entry 10 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,219 F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $145.63 to $146.60 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 476 | $145.01 | $69,026.19 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · nonDerivative · entry 9 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,695 F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $144.60 to $145.56 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,450 | $143.90 | $208,650.51 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · nonDerivative · entry 8 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,171 F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $143.58 to $144.54 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,718 | $142.92 | $531,380.65 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · nonDerivative · entry 7 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,621 F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $142.53 to $143.51 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,057 | $141.62 | $716,158.69 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · nonDerivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,339 F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $141.30 to $142.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,652 | $140.75 | $795,531.43 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · nonDerivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,396 F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $140.30 to $141.28 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,302 | $139.84 | $741,421.61 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,048 F1 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $139.29 to $140.26 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 10,754 | $25.02 | $269,065.08 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.